한글목차

구강암 치료 세계 시장은 2030년까지 25억 달러에 달할 전망

2023년에 19억 달러로 추정되는 구강암 치료 세계 시장은 2023-2030년 분석 기간에 CAGR 3.7%로 성장해 2030년에는 25억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 화학요법은 CAGR 4.7%로 성장을 지속하고, 분석 기간 종료까지 12억 달러에 달할 것으로 예측됩니다. 표적 치료 분야의 성장률은 분석 기간 동안 CAGR 3.3%로 추정됩니다.

미국 시장은 5억 2,870만 달러로 추정, 중국은 CAGR 7.1%로 성장 예측

미국의 구강암 치료 시장은 2023년 5억 2,870만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023-2030년 CAGR을 7.1%로 2030년까지 5억 2,840만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.2%와 2.8%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.

세계 구강암 치료 시장 - 주요 동향과 촉진요인 요약

구강 암은 구강, 입술, 혀, 뺨, 인두암을 포함하고 진단과 치료의 양면에서 큰 도전을 가져오는 세계 건강 문제입니다. 구강암 치료 전략은 종양의 병기와 부위, 환자의 건강 상태에 따라 다르며 일반적으로 수술, 방사선 요법, 화학 요법이 포함됩니다. 수술은 기능을 가능한 한 온존하면서 암 조직을 절제하는 것을 목적으로 하며, 방사선요법은 고에너지의 방사선을 사용하여 암세포를 노려서 사멸시키는 것으로 화학요법은 암세포 를 파괴하는 약물을 사용하는 것으로, 재발의 위험을 줄이기 위해 다른 치료법과 병용되는 경우가 많습니다. 최근에는 표적요법이나 면역요법도 도입되어 정상세포를 손상시키지 않고 암세포를 특이적으로 공격하거나 암과 싸우는 면역계의 능력을 높임으로써 새로운 희망을 가져오고 있습니다.

구강암 치료에 대한 접근은 의료기술의 진보와 질병의 근저에 있는 분자 메커니즘의 보다 깊은 이해에 영향을 받으며 최근 크게 진화하고 있습니다. 프리시전 메디신(정밀의료)이 보급되어 환자와 종양의 유전자 프로파일에 맞춘 치료가 이루어지게 되어 치료 효과가 높아지고 부작용이 최소화됩니다. 로봇 수술 및 강도조절 방사선 치료(IMRT)와 같은 기술 혁신은 보다 정밀하고 침습이 적은 치료법을 가능하게 하여 환자의 회복 기간과 치료 성적을 개선하고 있습니다. 또한, 새로운 화학요법제 및 생물학적 제제의 개발은 이용가능한 치료법의 폭을 넓히고 있습니다. 이러한 치료에 대한 반응을 예측할 수 있는 바이오마커의 동정에 대한 조사도 계속되고 있으며, 보다 개별화되고 효과적인 관리 전략이 촉진되고 있습니다.

구강암 치료 시장의 성장은 담배 사용이나 인유두종 바이러스(HPV) 감염 증가가 주요 요인이 되어, 세계에서 구강암 발생률이 상승하고 있는 등 몇 가지 요인에 의해 견인 되었습니다. 또한 구강암에 대한 인식이 높아져 조기 발견과 치료 개시로 이어지고 있습니다. 향상된 영상 진단 및 분자진단과 같은 진단 기술의 발전으로 진단의 정확성이 향상되고 치료 효과를 모니터링할 수 있어 시장이 더욱 확대되고 있습니다. 또한 환자가 더 나은 치료 결과와 부작용이 적은 치료를 적극적으로 요구하는 소비자 행동의 변화가 새로운 치료법 개발에 영향을 미칩니다. 세계의 건강 관리 인프라 확충과 신흥국의 의료 지출 증가는 진보된 치료에 대한 접근 확대를 가져와 시장 성장에 기여하고 있습니다. 마지막으로, 신규 치료제나 치료 방법에 관한 지속적인 조사가 이 분야의 기술 혁신을 뒷받침하고 있으며, 장래에는 구강암의 관리가 개선될 것으로 기대됩니다.

조사 대상 기업 예(전 86건)

• AbbVie, Inc.
• ALX Oncology, Inc.
• AstraZeneca PLC
• Exelixis, Inc.
• Genentech, Inc.
• GSK Plc
• Iovance Biotherapeutics
• Kura Oncology
• Merck & Co., Inc.
• NeoImmuneTech
• Privo Technologies
• Rakuten Medical
• Regeneron Pharmaceuticals, Inc.
• Sirnaomics, Inc.
• Vaccinex Inc.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트(UAE)
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global Oral Cancer Treatment Market to Reach US$2.5 Billion by 2030

The global market for Oral Cancer Treatment estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Targeted Therapy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 7.1% CAGR

The Oral Cancer Treatment market in the U.S. is estimated at US$528.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$528.4 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Oral Cancer Treatment Market - Key Trends and Drivers Summarized

Oral cancer, encompassing cancers of the mouth, lips, tongue, cheeks, and throat, is a significant global health concern that poses substantial challenges in terms of both diagnosis and treatment. Treatment strategies for oral cancer depend on the stage and location of the tumor, as well as the overall health of the patient, and typically include surgery, radiation therapy, and chemotherapy. Surgery aims to remove the cancerous tissue while preserving as much function as possible; radiation therapy uses high-energy rays to target and kill cancer cells; and chemotherapy involves the use of drugs to destroy cancer cells, often used in conjunction with other treatments to reduce the risk of recurrence. Recently, targeted therapy and immunotherapy have also been introduced, offering new hope by specifically attacking cancer cells without harming normal cells, or by boosting the immune system's ability to fight cancer.

The approach to oral cancer treatment has evolved significantly over recent years, influenced by advancements in medical technology and a better understanding of the molecular mechanisms underlying the disease. Precision medicine is becoming more prevalent, with treatments being tailored to the genetic profile of both the patient and the tumor, thereby enhancing the efficacy and minimizing the side effects. Technological innovations such as robotic surgery and intensity-modulated radiation therapy (IMRT) allow for more precise and less invasive treatment options, improving recovery times and outcomes for patients. Moreover, the development of new chemotherapeutic agents and biologic drugs are broadening the spectrum of available therapies. Research continues into the identification of biomarkers that can predict response to these treatments, facilitating more personalized and effective management strategies.

The growth in the oral cancer treatment market is driven by several factors, including the rising incidence of oral cancer worldwide, driven largely by increasing tobacco use and human papillomavirus (HPV) infections. There is also a growing awareness of the disease, leading to earlier detection and treatment initiation. Advances in diagnostic technologies, such as enhanced imaging and molecular diagnostics, are improving the precision of diagnosis and the monitoring of treatment response, further propelling the market. Additionally, changes in consumer behavior, with patients actively seeking out treatments that offer better outcomes and fewer side effects, are influencing the development of new therapies. The expansion of healthcare infrastructure globally and increased healthcare spending in emerging economies provide greater access to sophisticated treatments, contributing to market growth. Lastly, ongoing research into novel therapeutic agents and treatment modalities continues to drive innovation in the field, promising better management of oral cancer in the future.

Select Competitors (Total 86 Featured) -

• AbbVie, Inc.
• ALX Oncology, Inc.
• AstraZeneca PLC
• Exelixis, Inc.
• Genentech, Inc.
• GSK Plc
• Iovance Biotherapeutics
• Kura Oncology
• Merck & Co., Inc.
• NeoImmuneTech
• Privo Technologies
• Rakuten Medical
• Regeneron Pharmaceuticals, Inc.
• Sirnaomics, Inc.
• Vaccinex Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Oral Cancer Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rise in Tobacco and Smoking Addiction as Major Risk Factors Sets the Stage for Growth
  • Advances in Radiotherapy Propel Treatment Adoption
  • Increasing Focus on Early Diagnosis Strengthens Business Case for Oral Cancer Treatment
  • Expansion of Immunotherapy Spurs Market Adoption
  • Growing Awareness and Screening Programs Expands Addressable Market Opportunity
  • Increasing Adoption of Chemotherapy in Combination Therapies Propels Market Growth
  • Expansion of Health Insurance Coverage Strengthens Market Adoption
  • Increasing Availability of Advanced Diagnostic Tools Strengthens Market Dynamics
  • Government Funding and Support for Cancer Research Drives Market Growth
  • Rising Demand for Palliative Care Expands Market Reach
  • Growth of the Aging Population Sets the Stage for Market Expansion
  • Increasing Use of Artificial Intelligence in Treatment Planning Generates New Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Oral Cancer Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Oral Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Oral Cancer Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Oral Cancer Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: Australia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: Australia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• INDIA
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 113: India Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: India 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 116: India Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: India 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: South Korea 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: South Korea 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Oral Cancer Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: Argentina 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: Argentina 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: Brazil 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Brazil 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Mexico 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Mexico 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 160: Rest of Latin America 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 163: Rest of Latin America 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Oral Cancer Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Oral Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 175: Iran 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 178: Iran 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 181: Israel 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 184: Israel 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 187: Saudi Arabia 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 190: Saudi Arabia 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 193: UAE 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 196: UAE 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 199: Rest of Middle East 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 202: Rest of Middle East 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
• AFRICA
  • Oral Cancer Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Oral Cancer Treatment by Therapy - Chemotherapy, Targeted Therapy and Immunotherapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 205: Africa 16-Year Perspective for Oral Cancer Treatment by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Targeted Therapy and Immunotherapy for the Years 2014, 2024 & 2030
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Oral Cancer Treatment by End-Use - Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 208: Africa 16-Year Perspective for Oral Cancer Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION